Page last updated: 2024-10-27

glimepiride and Cataract

glimepiride has been researched along with Cataract in 1 studies

glimepiride: structure given in first source

Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
" neither toxic effects nor pathological changes were observed in the treated animals."1.29Subchronic and chronic toxicity of the new sulfonylurea glimepiride in dogs. ( Brunk, R; Mayer, D; Schollmeier, U, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schollmeier, U1
Brunk, R1
Mayer, D1

Other Studies

1 other study available for glimepiride and Cataract

ArticleYear
Subchronic and chronic toxicity of the new sulfonylurea glimepiride in dogs.
    Arzneimittel-Forschung, 1993, Volume: 43, Issue:10

    Topics: Animals; Blood Cell Count; Blood Chemical Analysis; Blood Glucose; Cataract; Dogs; Electrocardiograp

1993